|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.450 CNY | +7.68% |
|
+12.37% | +86.96% |
| 08-04 | Harbin Pharma's Two Drugs Recommended for China's Centralized Drug Procurement Listing | MT |
| 07-30 | Harbin Pharmaceutical Gets Marketing Approval for Potassium Sulfate API | MT |
| Market Cap | 17.05B 2.53B 2.19B 2.04B 1.88B 3.55B 240B 3.59B 24.11B 9.42B 120B 9.48B 9.28B 398B | P/E 2026 * |
35.8x | P/E 2027 * | 30.7x |
|---|---|---|---|---|---|
| Enterprise Value | 17.05B 2.53B 2.19B 2.04B 1.88B 3.55B 240B 3.59B 24.11B 9.42B 120B 9.48B 9.28B 398B | EV / Sales 2026 * |
1.04x | EV / Sales 2027 * | 1.01x |
| Free-Float |
47.74% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +7.68% | ||
| 1 week | +12.37% | ||
| Current month | +9.51% | ||
| 1 month | +105.41% | ||
| 3 months | +80.17% | ||
| 6 months | +83.76% | ||
| Current year | +86.96% |
| 1 week | 5.2 |  | 6.58 |
| 1 month | 3.03 | | 6.58 |
| Current year | 2.84 | | 6.58 |
| 1 year | 2.84 | | 6.58 |
| 3 years | 2.41 | | 6.58 |
| 5 years | 2.41 | | 6.58 |
| 10 years | 2.38 | | 9.77 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chuan You Lu
CEO | Chief Executive Officer | 64 | 27/12/2023 |
Xiao Dong Meng
DFI | Director of Finance/CFO | 54 | 24/12/2004 |
Kun Yu Ma
IRC | Investor Relations Contact | 45 | 27/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ai Dong Lou
BRD | Director/Board Member | 60 | 01/12/2020 |
Zhao Hua Li
BRD | Director/Board Member | 60 | 08/01/2021 |
Xiao Ping Hu
CHM | Chairman | 56 | 27/12/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/07/24 | Sell | 36,000 | 0.0014% | |||
| 01/07/24 | Sell | 27,000 | 0.0011% | |||
| 01/07/24 | Sell | Chief Financial Officer | 90,000 | 0.0036% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.68% | +12.37% | +60.05% | +93.11% | 2.41B | |
| +4.88% | -1.87% | +55.02% | +161.49% | 995B | |
| +0.62% | -3.17% | +50.59% | +48.54% | 614B | |
| +1.77% | -6.07% | +24.56% | +64.51% | 431B | |
| +1.52% | +0.33% | +42.09% | +37.02% | 353B | |
| +0.27% | -3.56% | +31.06% | +39.25% | 293B | |
| +2.68% | -8.18% | +7.49% | +10.78% | 245B | |
| +6.05% | +6.79% | +37.95% | +63.66% | 210B | |
| -4.23% | -13.06% | -3.92% | -46.14% | 210B | |
| -2.48% | +0.20% | +18.26% | +64.87% | 168B | |
| Average | +1.84% | -2.48% | +32.31% | +53.71% | 352.07B | |
| Weighted average by Cap. | +2.03% | -5.87% | +37.65% | +73.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.4B 2.43B 2.11B 1.97B 1.81B 3.42B 231B 3.46B 23.19B 9.07B 116B 9.12B 8.92B 383B | 16.94B 2.51B 2.18B 2.03B 1.87B 3.53B 239B 3.57B 23.95B 9.36B 119B 9.42B 9.22B 395B |
| Net income | 452M 66.97M 58.15M 54.22M 49.81M 94.2M 6.37B 95.23M 639M 250M 3.18B 251M 246M 10.55B | 520M 77.09M 66.94M 62.41M 57.33M 108M 7.33B 110M 736M 288M 3.67B 289M 283M 12.15B |
| Net Debt | - | - |
Employees
10,039
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/08/26 | CN¥6.450 | +7.68% | 489,039,768 |
| 03/08/26 | CN¥5.990 | +1.70% | 398,720,396 |
| 31/07/26 | CN¥5.890 | +5.94% | 429,241,630 |
| 30/07/26 | CN¥5.560 | +3.73% | 401,525,162 |
| 29/07/26 | CN¥5.360 | -6.62% | 392,777,111 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.450CNY
Average target price
4.310CNY
Spread / Average Target
-33.18%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600664 Stock
Select your edition
All financial news and data tailored to specific country editions
